Evidence map›Paper›PMID 39773827›Full record

ArticleEuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology2025

High-risk percutaneous coronary intervention in patients with reduced left ventricular ejection fraction deemed not suitable for surgical revascularisation. A clinical consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) in collaboration with the ESC Working Group on Cardiovascular Surgery.

Andreas Schäfer, Mirvat Alasnag, Daniele Giacoppo, Carlos Collet, Tanja K Rudolph, Ariel Roguin, Piotr P Buszman, Roisin Colleran, Giulio Stefanini, Thierry Lefevre and 17 more

Abstract readConsensus Statement
In one paragraph

Article in EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Patient selection for complex, high-risk indicated percutaneous coronary intervention procedures: an overview.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  5. Impella™-protected PCI in a post-CABG patient with advanced biventricular dysfunction and mitral regurgitation.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  6. Article
  7. Contemporary evidence in protected percutaneous coronary intervention: a case-based review.European heart journal supplements : journal of the European Society of Cardiology · 2026
    Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors.

Andreas SchäferCardiac Arrest Center, Department of Cardiology and Angiology, Hannover Medical School, Hanover, Germany.
Mirvat AlasnagCardiac Center, King Fahd Armed Forces Hospital, Jeddah, Saudi Arabia.
Daniele GiacoppoDepartment of Cardiology, Alto Vicentino Hospital, Santorso, Italy.
Carlos ColletDepartment of Cardiology, Cardiovascular Center Aalst, Aalst, Belgium.
Tanja K RudolphDepartment of Cardiology, Heart and Diabetes Center NRW, Ruhr-University, Bad Oeynhausen, Germany.
Ariel RoguinDepartment of Cardiology, Hillel Yaffe Medical Center, Hadera, Israel.
Piotr P BuszmanDepartment of Cardiology, Andrzej Frycz Modrzewski Kraków University, Krakow, Poland and Center for Cardiology and Cardiac Surgery of American Heart of Poland, Bielsko-Biała, Poland.
Roisin ColleranDepartment of Cardiology, Mater Private Hospital, Dublin, Ireland.
Giulio StefaniniDepartment of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
Thierry LefevreHôpital privé Jacques Cartier, Institut Cardiovasculaire Paris Sud, Massy, France.
Nicolas Van MieghemDepartment of Cardiology, Thoraxcenter, Erasmus University Medical Center, Rotterdam, the Netherlands.
Guillaume CaylaDepartment of Cardiology, University Hospital Nîmes, University of Montpellier, Nîmes, France.
Christoph NaberDepartment of Cardiology and Internal Intensive Care, Wilhelmshaven Hospital, Wilhelmshaven, Germany.
Andreas BaumbachCentre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.
Adam WitkowskiDepartment of Interventional Cardiology and Angiology, National Institute of Cardiology, Warsaw, Poland.
Francesco BurzottaDepartment of Cardiovascular Sciences, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
Davide CapodannoDivision of Cardiology, AOU Policlinico "G. Rodolico-San Marco", University of Catania, Catania, Italy.
Dariusz DudekDepartment of Cardiology, Jagiellonian University Medical College, Krakow, Poland.
Rasha Al-LameeImperial College London, Imperial College Healthcare NHS Trust, London, United Kingdom.
Adrian BanningDepartment of Cardiology, John Radcliffe Hospital, Oxford, United Kingdom.
Philip MacCarthyKing's College Hospital, London, United Kingdom.
Roman GottardiDepartment of Cardiovascular Surgery, Heart Center Lahr, Lahr, Germany.
Florian S SchoenhoffDepartment of Cardiac Surgery, University Hospital Bern, Bern, Switzerland.
Martin CzernyDepartment of Cardiovascular Surgery, University Heart Center Freiburg - Bad Krozingen, Bad Krozingen, Germany.
Matthias ThielmannDepartment of Thoracic and Cardiovascular Surgery, West-German Heart & Vascular Center Essen at University Duisburg-Essen, Essen, Germany.
Nikos WernerDepartment of Cardiology, Heart Center Trier, Krankenhaus der Barmherzigen Brüder, Trier, Germany.
Giuseppe TarantiniDepartment of Cardiac-Thoracic-Vascular Sciences, University of Padua, Padua, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This clinical consensus statement of the European Association of Percutaneous Cardiovascular Interventions was developed in association with the European Society of Cardiology Working Group on Cardiovascular Surgery. It aims to define procedural and contemporary technical requirements that may improve the efficacy and safety of percutaneous coronary intervention (PCI), both in the acute phase and at long-term follow-up, in a high-risk cohort of patients on optimal medical therapy when clinical and anatomical high-risk criteria are present that entail unacceptable surgical risks, precluding the feasibility of coronary artery bypass grafting (CABG). This document pertains to patients with surgical contraindication according to the Heart Team, in whom medical therapy has failed (e.g., residual symptoms), and for whom the Heart Team estimates that revascularisation may have a prognostic benefit (e.g., left main, last remaining vessel, multivessel disease with large areas of ischaemia); however, there is a lack of data regarding the size of this patient population. This document aims to guide interventional cardiologists on how to proceed with PCI in such high-risk patients with reduced left ventricular ejection fraction after the decision of the Heart Team is made that CABG - which overall is the guideline-recommended option for revascularisation in these patients - is not an option and that PCI may be beneficial for the patient. Importantly, when a high-risk PCI is planned, a multidisciplinary decision by interventional cardiologists, cardiac surgeons, anaesthetists and non-invasive physicians with expertise in heart failure management and intensive care should be agreed upon after careful consideration of the possible undesirable consequences of PCI, including futility, similar to the approach for structural interventions.

Indexed as

Percutaneous Coronary InterventionStroke VolumeCoronary Artery DiseaseHumansPatient SelectionRisk AssessmentRisk FactorsTreatment OutcomeVentricular Dysfunction, LeftVentricular Function, Left

Identifiers

PMID39773827
PMCPMC11687390

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.